DK0635269T3 - Anvendelse af N-(pyridinyl)-1H-indol-l-aminer til fremstilling af et lægemiddel til behandling af obsessiv-kompulsive lidel - Google Patents

Anvendelse af N-(pyridinyl)-1H-indol-l-aminer til fremstilling af et lægemiddel til behandling af obsessiv-kompulsive lidel

Info

Publication number
DK0635269T3
DK0635269T3 DK94110875T DK94110875T DK0635269T3 DK 0635269 T3 DK0635269 T3 DK 0635269T3 DK 94110875 T DK94110875 T DK 94110875T DK 94110875 T DK94110875 T DK 94110875T DK 0635269 T3 DK0635269 T3 DK 0635269T3
Authority
DK
Denmark
Prior art keywords
preparation
treatment
obsessive
pyridinyl
indole
Prior art date
Application number
DK94110875T
Other languages
Danish (da)
English (en)
Inventor
Sathapana Kongsamut
Craig Paul Smith
Ann Theresa Woods
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DK0635269T3 publication Critical patent/DK0635269T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK94110875T 1993-07-19 1994-07-13 Anvendelse af N-(pyridinyl)-1H-indol-l-aminer til fremstilling af et lægemiddel til behandling af obsessiv-kompulsive lidel DK0635269T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/092,848 US5356910A (en) 1993-07-19 1993-07-19 Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder

Publications (1)

Publication Number Publication Date
DK0635269T3 true DK0635269T3 (da) 2000-04-25

Family

ID=22235450

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94110875T DK0635269T3 (da) 1993-07-19 1994-07-13 Anvendelse af N-(pyridinyl)-1H-indol-l-aminer til fremstilling af et lægemiddel til behandling af obsessiv-kompulsive lidel

Country Status (21)

Country Link
US (1) US5356910A (ja)
EP (1) EP0635269B1 (ja)
JP (1) JP2807633B2 (ja)
KR (1) KR100325276B1 (ja)
AT (1) ATE186215T1 (ja)
AU (1) AU673747B2 (ja)
CA (1) CA2128312C (ja)
CZ (1) CZ288593B6 (ja)
DE (1) DE69421457T2 (ja)
DK (1) DK0635269T3 (ja)
EG (1) EG20716A (ja)
ES (1) ES2138017T3 (ja)
GR (1) GR3032292T3 (ja)
HU (1) HU217063B (ja)
MX (1) MX9405209A (ja)
NO (1) NO306597B1 (ja)
NZ (1) NZ264015A (ja)
PL (1) PL304335A1 (ja)
RU (1) RU2164795C2 (ja)
TW (1) TW349864B (ja)
ZA (1) ZA945236B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459274A (en) * 1994-05-13 1995-10-17 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines
US5776955A (en) * 1995-07-27 1998-07-07 Hoechst Marion Roussel, Inc. Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
CN1184969C (zh) * 1995-07-27 2005-01-19 阿温蒂斯药物公司 未取代和取代的n-(吡咯-1-基)吡啶胺作为抗惊厥药的用途
JP4608723B2 (ja) * 1999-03-10 2011-01-12 東ソー株式会社 置換インドール誘導体の製造方法
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
FR2892022B1 (fr) * 2005-10-19 2008-01-04 Urogene Sa Traitement des symptomes de l'irritation de la vessie
FR2892021B1 (fr) * 2005-10-19 2008-01-04 Urogene Traitement de l'incontinence urinaire d'effort et mixte
FR2897614B1 (fr) * 2006-02-20 2008-05-23 Urogene Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US4880822A (en) * 1987-04-24 1989-11-14 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyridinyl)-1H-indol-1-amines
ATE115143T1 (de) 1987-04-24 1994-12-15 Hoechst Roussel Pharma N-(pyridinyl)-1h-indol-1-amine, verfahren zu deren herstellung und ihre verwendung als arzneimittel.
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
US5214038A (en) * 1991-04-15 1993-05-25 Hoechst-Roussel Pharmaceuticals Inc. 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof
US5177088A (en) 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5185350A (en) 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles

Also Published As

Publication number Publication date
DE69421457D1 (de) 1999-12-09
KR950002761A (ko) 1995-02-16
ES2138017T3 (es) 2000-01-01
ATE186215T1 (de) 1999-11-15
US5356910A (en) 1994-10-18
NZ264015A (en) 1997-07-27
DE69421457T2 (de) 2000-05-04
EP0635269B1 (en) 1999-11-03
AU673747B2 (en) 1996-11-21
HU217063B (hu) 1999-11-29
GR3032292T3 (en) 2000-04-27
HUT69709A (en) 1995-09-28
KR100325276B1 (ko) 2002-09-25
EG20716A (en) 1999-12-29
PL304335A1 (en) 1995-01-23
AU6753194A (en) 1995-01-27
NO942695L (no) 1995-01-20
HU9402124D0 (en) 1994-09-28
MX9405209A (es) 1995-01-31
RU94026084A (ru) 1996-08-27
CZ173094A3 (en) 1995-02-15
CA2128312C (en) 2004-09-28
JP2807633B2 (ja) 1998-10-08
NO942695D0 (no) 1994-07-18
ZA945236B (en) 1995-02-28
CZ288593B6 (cs) 2001-07-11
TW349864B (en) 1999-01-11
CA2128312A1 (en) 1995-01-20
RU2164795C2 (ru) 2001-04-10
EP0635269A1 (en) 1995-01-25
JPH0753376A (ja) 1995-02-28
NO306597B1 (no) 1999-11-29

Similar Documents

Publication Publication Date Title
NO985711D0 (no) Farmas°ytikum for behandling av neurologiske og neuropsykiatriske mangler
MX9707453A (es) Derivados de quinazolina.
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
PL314086A1 (en) Novel (r)-8-fluoro-3-n,n-substituted amino 3,4-dihydro 5-carbamoyl-2h-1-bezopyranes
JO1613B1 (en) Derivatives of n - (3-hydroxy-4-piperidnil) dihydrobenzofuran, dihydro-2u-benzopyran or dihydro-benzodoxine) carboxymide
MXPA04000278A (es) Uso de antagonistas del receptor nk-1 con estructura piridinica para tratamiento de lesiones cerebrales, espinales o neuronales.
AP9701041A0 (en) Pyridylpyrrole compounds.
DK0635269T3 (da) Anvendelse af N-(pyridinyl)-1H-indol-l-aminer til fremstilling af et lægemiddel til behandling af obsessiv-kompulsive lidel
CA2282279A1 (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
SE9302218D0 (sv) New use
BR0207307A (pt) Inibidores de glyt-1
MX9709396A (es) Derivados de fenoxipiperazina para el tratamiento de transtornos del sistema dopamina.